SCHEMBL29800015

SCHEMBL29800015

COC(=O)c1c(N(Cc2ccc(F)cc2F)C(C)=O)sc2c(Cl)c(O)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.35
▸ HSP90B1 P14625 2/20 0.35
▸ MAPT P10636 2/20 0.33
▸ MAOB P27338 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MDM2 Q00987 2/20 0.33
▸ MAPK14 Q16539 3/20 0.33
▸ RIPK1 Q13546 2/20 0.33
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ TSPO P30536 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ BDKRB1 P46663 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683874 1.00 HSP90AA1 (0.35) HSP90AA1HSP90B1MAPTMAOBKDM4E
SCHEMBL24683895 0.92 BCKDK (0.35) MAOBMEN1KMT2AMDM2MAPK14
SCHEMBL29799909 0.92 BCKDK (0.35) MAOBMEN1KMT2AMDM2MAPK14
SCHEMBL30664667 0.89 GPER1 (0.35) MAOBMDM2MAPK14RIPK1
SCHEMBL24683858 0.89 GPER1 (0.35) MAOBMDM2MAPK14RIPK1
SCHEMBL24683191 0.89 HSP90AA1 (0.38) HSP90AA1HSP90B1KDM4EMEN1KMT2A
SCHEMBL30664665 0.89 HSP90AA1 (0.38) HSP90AA1HSP90B1KDM4EMEN1KMT2A
SCHEMBL24682827 0.87 RIPK1 (0.34) HSP90AA1HSP90B1MAPTMAOBKDM4E
SCHEMBL24682815 0.87 HSP90AA1 (0.39) HSP90AA1HSP90B1MAPTKDM4EMEN1
SCHEMBL30664654 0.87 HSP90AA1 (0.39) HSP90AA1HSP90B1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 HSP90AA1 890/4885HSP90B1 2446/4885MAPT 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback